Related Experiment Video
Updated: Oct 1, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
A clinical profile of infective endocarditis in patients with recent COVID-19: A systematic review
Juan A Quintero-Martinez1, Joya-Rita Hindy1, Maryam Mahmood1
1Division of Infectious Diseases, Departments of Medicine and Cardiovascular Diseases, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Insights
Infective endocarditis (IE) is a potential complication following Coronavirus disease 2019 (COVID-19). This systematic review characterizes IE in COVID-19 patients, revealing key clinical features and outcomes.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) is associated with cardiovascular complications and increased mortality.
- Infective endocarditis (IE) is a recognized complication in patients with recent COVID-19 infections.
- Limited characterization exists for IE following COVID-19 infection.
Purpose of the Study:
- To systematically review and analyze the clinical features and outcomes of infective endocarditis (IE) in patients with a history of COVID-19.
- To provide a comprehensive profile of IE as a complication of COVID-19.
Main Methods:
- A systematic review of 8 databases was conducted for published reports of IE in patients with confirmed COVID-19.
- Data extraction included clinical characteristics, microbiological findings, outcomes, and procedures based on modified Duke criteria.
Main Results:
- Twenty articles comprising 323 reports met inclusion criteria, with a mean patient age of 52.2 years (76.2% male).
- Staphylococcus aureus was the most common pathogen (38.1%). The mean interval between COVID-19 and IE diagnosis was 16.7 days.
- Twenty-eight percent required critical care, 33.3% underwent cardiac surgery, and 23.8% died during hospitalization.
Conclusions:
- This systematic review outlines the clinical profile and outcomes of IE post-COVID-19 infection.
- Clinicians must recognize IE as a potential and unique complication of COVID-19, especially during the ongoing pandemic.
Background:
Coronavirus disease 2019 (COVID-19) can progress to cardiovascular complications which are linked to higher in-hospital mortality rates. Infective endocarditis (IE) can develop in patients with recent COVID-19 infections, however, characterization of IE following COVID-19 infection has been lacking. To better characterize this disease, we performed a systematic review with descriptive analysis of the clinical features and outcomes of these patients.
Methods:
Our search was conducted in 8 databases for all published reports of probable or definite IE in patients with a prior COVID-19 confirmed diagnosis. After ensuring an appropriate inclusion of the articles, we extracted data related to clinical characteristics, modified duke criteria, microbiology, outcomes, and procedures.
Results:
Searches generated a total of 323 published reports, and 20 articles met our inclusion criteria. The mean age of patients was 52.2 ± 16.9 years and 76.2% were males. Staphylococcus aureus was isolated in 8 (38.1%) patients, Enterococcus faecalis in 3 patients (14.3%) and Streptococcus mitis/oralis in 2 (9.5%) patients. The mean time interval between COVID-19 and IE diagnoses was 16.7 ± 15 days. Six (28.6%) patients required critical care due to IE, 7 patients (33.3%) underwent IE-related cardiac surgery and 5 patients (23.8%) died during their IE hospitalization.
Conclusions:
Our systematic review provides a profile of clinical features and outcomes of patients with a prior COVID-19 infection diagnosis who subsequently developed IE. Due to the ongoing COVID-19 pandemic, it is essential that clinicians appreciate the possibility of IE as a unique complication of COVID-19 infection.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

